Universal vaccination against hepatitis B at birth is safe, effective and protective for both individual and public health. The evidence review found that there is no evidence to support the CDC's recent change in vaccine recommendations. This review contradicts the CDC's controversial decision. Vaccination protects against hepatitis B effectively. No data in the survey support concerns about the safety of the vaccine in newborns. The CDC's decision to change the recommendations is not supported by the available evidence.